HIV DNA and dementia in treatment-naïve HIV-1-infected individuals in Bangkok, Thailand

International Journal of Medical Sciences

Volumn 4, Issue 1, 2007, Pages 13-18

  Shiramizu, Bruce ^a,g   Ratto Kim, Silvia ^a,b   Sithinamsuwan, Pasiri ^c   Nidhinandana, Samart ^c   Thitivichianlert, Sataporn ^c   Watt, George ^a   DeSouza, Mark ^b   Chuenchitra, Thippawan ^b   Sukwit, Suchitra ^b   Chitpatima, Suwicha ^d   Robertson, Kevin ^e   Paul, Robert ^f   Shikuma, Cecilia ^a   Valcour, Victor ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^c PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^d Royal Thai Army   (Thailand)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^g Young Bldg   (United States)

Author keywords

Cognition; Dementia; HIV DNA; Human immunodeficiency virus type 1

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUROPATHOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; THAILAND;

EID: 33846075354     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.4.13     Document Type: Article

References (34)

1. Collman RG, Perno CF, Crowe SM, Stevenson M, and Montaner LJ. HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions. J Leukoc Biol. 2003; 74: 631-634.
2. Aquaro S, Bagnarelli P, Guenci T, et al. Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus. J Med Virol. 2002; 68: 479-488.
3. Wong JK, Hezareh M, Gunthard HF, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997; 278: 1291-1295.
4. Crowe S, Zhu T, and Muller WA. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J Leukoc Biol. 2003; 74: 635-641.
5. Siliciano RF. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution. Top HIV Med. 2005; 13: 96-100.
6. Delobel P, Sandres-Saune K, Cazabat M, et al. Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART. AIDS. 2005; 19: 1739-1750.
7. Crowe SM and Sonza S. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J Leukoc Biol. 2000; 68: 345-350.
8. Bagasra O and Pomerantz RJ. Human immunodeficiency virus type I provirus is demonstrated in peripheral blood monocytes in vivo: a study utilizing an in situ polymerase chain reaction. AIDS Res Hum Retroviruses. 1993; 9: 69-76.
9. Innocenti P, Ottmann M, Morand P, Leclercq P, and Seigneurin JM. HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. AIDS Res Hum Retroviruses. 1992; 8: 261-268.
10. Verani A, Gras G, and Pancino G. Macrophages and HIV-1: dangerous liaisons. Mol Immunol. 2005; 42: 195-212.
11. Sonza S, Maerz A, Deacon N, et al. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol. 1996; 70: 3863-3869.
12. González-Scarano F and Martín-García J. The neuropathogenesis of AIDS. Nature Reviews Immunology. 2005; 5: 69-81.
13. Gartner S. HIV infection and dementia. Science. 2000; 287: 602-604.
14. Gendelman HE, Lipton SA, Tardieu M, Bukrinsky MI, and Nottet HS. The neuropathogenesis of HIV-1 infection. J Leukoc Biol. 1994; 56: 389-398.
15. Shiramizu B, Gartner S, Williams A, et al. Circulating proviral HIV DNA and HIV-associated dementia. AIDS. 2005; 19: 45-52.
16. Sacktor NC, Wong M, Nakasujja N, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005; 19: 1367-1374.
17. Maj M, Janssen R, Starace F, et al. WHO Neuropsychiatric AIDS study, cross-sectional phase I. Study design and psychiatric findings. Arch Gen Psychiatry. 1994; 51: 39-49.
18. Lotrakul M and Sukanich P. Development of the Thai Depression Inventory. J Med Assoc Thai. 1999; 82: 1200-1207.
19. Gaywee J, Artenstein AW, VanCott TC, et al. Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand. J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 13: 392-396.
20. Mason CJ, Kitsiripornchai S, Markowitz LE, et al. Nationwide surveillance of HIV-1 prevalence and subtype in young Thai men. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 19: 165-173.
21. Shiramizu B, Williams A, Ratto-Kim S, et al. Activated Macrophages as a Potential Source of HIV DNA in HIV-1-Associated Dementia. In: 6th International Workshop on HIV, Cells of Macrophage/Dendritic Lineage, and Other Reservoirs. 2005. Verenna, Italy.
22. Viard JP, Burgard M, Hubert JB, et al. Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level. AIDS. 2004; 18: 45-49.
23. Havlir DV, Koelsch KK, Strain MC, et al. Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine. J Infect Dis. 2005; 191: 1164-1168.
24. Calcaterra S, Cappiello G, Di Caro A, Garbuglia AR, and Benedetto A. Comparative analysis of total and integrated HIV-1 DNA in peripheral CD4 lymphocytes and monocytes after long treatment with HAART. J Infect. 2001; 43: 239-245.
25. Rouzioux C, Hubert JB, Burgard M, et al. Early Levels of HIV-1 DNA in Peripheral Blood Mononuclear Cells Are Predictive of Disease Progression Independently of HIV-1 RNA Levels and CD4+ T Cell Counts. J Infect Dis. 2005; 192: 46-55.
26. Garbuglia AR, Zaccarelli M, Calcaterra S, et al. Dynamics of viral load in plasma and HIV DNA in lymphocytes during highly active antiretroviral therapy (HAART): high viral burden in macrophages after 1 year of treatment. J Chemother. 2001; 13: 188-194.
27. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature. 1997; 387: 188-191.
28. Garaci E, Palamara AT, Ciriolo MR, et al. Intracellular GSH content and HIV replication in human macrophages. J Leukoc Biol. 1997; 62: 54-59.
29. Gendelman HE, Orenstein JM, Martin MA, et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med. 1988; 167: 1428-1441.
30. Belmonte L, Bare P, Picchio GR, et al. Decreased recovery of replication-competent HIV-1 from peripheral blood mononuclear cell-derived monocyte/macrophages of HIV-positive patients after 3 years on highly active antiretroviral therapy. AIDS. 2002; 16: 1289-1292.
31. Sonza S, Mutimer HP, Oelrichs R, et al. Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS. 2001; 15: 17-22.
32. Zhu T, Muthui D, Holte S, et al. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol. 2002; 76: 707-716.
33. Xiong H, Zeng YC, Lewis T, et al. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. J Neurovirol. 2000; 6 (Suppl 1): S14-23.
34. Kedzierska K and Crowe SM. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem. 2002; 9: 1893-1903.